View source for Category:Advancing Breakthrough Devices for Patients Act

{{Infobox US Legislation
| name             = S. 1077: Advancing Breakthrough Devices for Patients Act of 2016<ref>{{cite web
|url=https://www.govtrack.us/congress/bills/114/s1077
|title=S. 1077 (114th)
|accessdate=August 17, 2016
|author=114th Congress (2015)
|date=April 23, 2015
|work=Legislation
|publisher=GovTrack.us
|quote=Advancing Breakthrough Devices for Patients Act of 2016
}}</ref>
| image            = LegislationReported.jpg
| full_title       = A bill to provide for expedited development of and priority review for breakthrough devices.
| introductionDate = Apr 23, 2015
| status           = Reported by Committee on Mar 9, 2016
| sponsor          = [[:Category:Richard Burr|Richard Burr]], Senior Senator from North Carolina, Republican
| prognosis        = 35% chance of being enacted
}}
{{cquote|This bill amends the Federal Food, Drug, and Cosmetic Act to expand the Food and Drug Administration's (FDA's) priority review of breakthrough medical devices to include all classes of devices. Currently, only class III (new or highest risk) devices are eligible. (Via Congressional Research Service summary)}} 

==See also==
*[[:Category:21st Century Cures Act|21st Century Cures Act]]
*[[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy (ECT)]]

==Notes==
{{Reflist}}

==External links==
[https://www.govtrack.us/congress/bills/114/s1077 S.1077 (114th Congress): Advancing Breakthrough Devices for Patients Act of 2015], GovTrack. Reported by Committee on Mar 9, 2016.

[[Category:FDA]]
[[Category:Legislation]]
[[Category:Psychiatric treatment]]